Premenstrual dysphoric disorder (PMDD) was recognized as an official psychiatric diagnosis among depressive disorders in the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5). The exact etiology of PMDD is not yet fully understood, and it is a topic of current research. The hope is that learning more about PMDD can lead to improved treatment modalities for this disorder and better understanding of other related disorders (such as premenstrual mood exacerbation and postpartum- or menopause-related mood disorders). Often misdiagnosed and likely underdiagnosed, PMDD has a 12-month prevalence that ranges from 1.8 to 5.8% for women who menstruate. Mental health providers who treat women of reproductive age should be familiar with the diagnostic criteria, related differential diagnosis, and available treatment modalities for PMDD.
This review contains 5 figures, 5 tables and 59 references
Key words: mood disorder, premenstrual dysphoric disorder, premenstrual exacerbation, premenstrual syndrome, reproductive mental health, reproductive psychiatry, women’s mental health
High utilizers were a small percentage of patients (6.0%) who accounted for a disproportionate number (23%) of 977 detoxification admissions. They had greater disease severity as manifest by more years of AUD. They were not more likely to have hospitalizations for other reasons or less likely to keep post discharge appointments. These patients may warrant different services tailored to prevent hospital readmissions for detoxification.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.